Targeting the alternative bile acid synthetic pathway for metabolic diseases
Open accessThe DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Abstract
The gut microbiota is profoundly involved in glucose and lipid metabolism, in part by regulating bile acid (BA) metabolism and affecting multiple BA-receptor signaling pathways. BAs are synthesized in the liver by multi-step reactions catalyzed via two distinct routes, the classical pathway (producing the 12α-hydroxylated primary BA, cholic acid), and the alternative pathway (producing the non-12α-hydroxylated primary BA, chenodeoxycholic acid). BA synthesis and excretion is a major pathway of cholesterol and lipid catabolism, and thus, is implicated in a variety of metabolic diseases including obesity, insulin resistance, and nonalcoholic fatty liver disease. Additionally, both oxysterols and BAs function as signaling molecules that activate multiple nuclear and membrane receptor-mediated signaling pathways in various tissues, regulating glucose, lipid homeostasis, inflammation, and energy expenditure. Modulating BA synthesis and composition to regulate BA signaling is an interesting and novel direction for developing therapies for metabolic disease. In this review, we summarize the most recent findings on the role of BA synthetic pathways, with a focus on the role of the alternative pathway, which has been under-investigated, in treating hyperglycemia and fatty liver disease. We also discuss future perspectives to develop promising pharmacological strategies targeting the alternative BA synthetic pathway for the treatment of metabolic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Self-citationIntestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Wahlström, A., Sayin, S. I., Marschall, H.-U., & Bäckhed, F. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.005 · Cited by 2,851
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Sayin, S. I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., & Bäckhed, F. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.003 · Cited by 2,331
Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
Jia, W., Xie, G., & Jia, W. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.119 · Cited by 1,924
Self-citationPleiotropic Roles of Bile Acids in Metabolism
de Aguiar Vallim, T. Q., Tarling, E. J., & Edwards, P. A. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.013 · Cited by 1,209
Chávez-Talavera, O., Tailleux, A., Lefebvre, P., & Staels, B. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.055 · Cited by 970
Huang, F., Zheng, X., Ma, X., Jiang, R., Zhou, W., Zhou, S., Zhang, Y., Lei, S., Wang, S., Kuang, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12896-x · Cited by 789
Self-citationIntestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
Fang, S., Suh, J. M., Reilly, S. M., Yu, E., Osborn, O., Lackey, D., Yoshihara, E., Perino, A., Jacinto, S., Lukasheva, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3760 · Cited by 738
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial
Lindor, K. D., Kowdley, K. V., Heathcote, J. E., Harrison, E. M., Jorgensen, R., Angulo, P., Lymp, J. F., Burgart, L., & Colin, P. (2004) · Hepatology · doi:10.1002/hep.20092 · Cited by 727
Bile acid receptors as targets for drug development
Schaap, F. G., Trauner, M., & Jansen, P. L. M. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.151 · Cited by 696
Min, H.-K., Kapoor, A., Fuchs, M., Mirshahi, F., Zhou, H., Maher, J., Kellum, J., Warnick, R., Contos, M. J., & Sanyal, A. J. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.004 · Cited by 652
Spencer, M. D., Hamp, T. J., Reid, R. W., Fischer, L. M., Zeisel, S. H., & Fodor, A. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.11.049 · Cited by 593
Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
Kim, I., Ahn, S.-H., Inagaki, T., Choi, M., Ito, S., Guo, G. L., Kliewer, S. A., & Gonzalez, F. J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700330-jlr200 · Cited by 592
Fu, L., John, L. M., Adams, S. H., Yu, X. X., Tomlinson, E., Renz, M., Williams, P. M., Soriano, R., Corpuz, R., Moffat, B., et al. (2004) · Endocrinology · doi:10.1210/en.2003-1671 · Cited by 579
Bile acids: Chemistry, physiology, and pathophysiology
Monte, M. J., Marin, J. J., Antelo, A., & Vazquez-Tato, J. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.804 · Cited by 569
Laurin, J., Lindor, K. D., Crippin, J. S., Gossard, A., Gores, G. J., Ludwig, J., Rakela, J., & McGill, D. B. (1996) · Hepatology · doi:10.1002/hep.510230624 · Cited by 566
Oram, J. F., & Heinecke, J. W. (2005) · Physiological Reviews · doi:10.1152/physrev.00005.2005 · Cited by 521
Laffitte, B. A., Chao, L. C., Li, J., Walczak, R., Hummasti, S., Joseph, S. B., Castrillo, A., Wilpitz, D. C., Mangelsdorf, D. J., Collins, J. L., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0830671100 · Cited by 502
Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation
Su, G. L. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00550.2001 · Cited by 480
Human Insulin Resistance Is Associated With Increased Plasma Levels of 12α-Hydroxylated Bile Acids
Haeusler, R. A., Astiarraga, B., Camastra, S., Accili, D., & Ferrannini, E. (2013) · Diabetes · doi:10.2337/db13-0639 · Cited by 444
Acyl‐coenzyme A:cholesterol acyltransferases
Chang, T.-Y., Li, B.-L., Chang, C. C. Y., & Urano, Y. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90926.2008 · Cited by 443
The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue Activity
Broeders, E. P. M., Nascimento, E. B. M., Havekes, B., Brans, B., Roumans, K. H. M., Tailleux, A., Schaart, G., Kouach, M., Charton, J., Deprez, B., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.002 · Cited by 439
Tang, R., Wei, Y., Li, Y., Chen, W., Chen, H., Wang, Q., Yang, F., Miao, Q., Xiao, X., Zhang, H., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-313332 · Cited by 434
Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23
Degirolamo, C., Sabbà, C., & Moschetta, A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.9 · Cited by 424
Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells
Trabelsi, M.-S., Daoudi, M., Prawitt, J., Ducastel, S., Touche, V., Sayin, S. I., Perino, A., Brighton, C. A., Sebti, Y., Kluza, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms8629 · Cited by 400
Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH
Caballero, F., Fernández, A., De Lacy, A. M., Fernández-Checa, J. C., Caballería, J., & García-Ruiz, C. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.016 · Cited by 368
Hepatic insulin resistance directly promotes formation of cholesterol gallstones
Biddinger, S. B., Haas, J. T., Yu, B. B., Bezy, O., Jing, E., Zhang, W., Unterman, T. G., Carey, M. C., & Kahn, C. R. (2008) · Nature Medicine · doi:10.1038/nm1785 · Cited by 368
Villablanca, E. J., Raccosta, L., Zhou, D., Fontana, R., Maggioni, D., Negro, A., Sanvito, F., Ponzoni, M., Valentinis, B., Bregni, M., et al. (2010) · Nature Medicine · doi:10.1038/nm.2074 · Cited by 335
Oxysterols: From cholesterol metabolites to key mediators
Mutemberezi, V., Guillemot-Legris, O., & Muccioli, G. G. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.09.002 · Cited by 335
Worthmann, A., John, C., Rühlemann, M. C., Baguhl, M., Heinsen, F.-A., Schaltenberg, N., Heine, M., Schlein, C., Evangelakos, I., Mineo, C., et al. (2017) · Nature Medicine · doi:10.1038/nm.4357 · Cited by 318
Mueller, M., Thorell, A., Claudel, T., Jha, P., Koefeler, H., Lackner, C., Hoesel, B., Fauler, G., Stojakovic, T., Einarsson, C., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.034 · Cited by 312
Brown, A. J., & Jessup, W. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.02.005 · Cited by 309
The gut microbiota and metabolic disease: current understanding and future perspectives
Arora, T., & Bäckhed, F. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12508 · Cited by 303
Wikström Shemer, E., Marschall, H., Ludvigsson, J., & Stephansson, O. (2013) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12174 · Cited by 299
Higuchi, N., Kato, M., Shundo, Y., Tajiri, H., Tanaka, M., Yamashita, N., Kohjima, M., Kotoh, K., Nakamuta, M., Takayanagi, R., et al. (2008) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00382.x · Cited by 286
A Liver-Enriched Long Non-Coding RNA, lncLSTR, Regulates Systemic Lipid Metabolism in Mice
Li, P., Ruan, X., Yang, L., Kiesewetter, K., Zhao, Y., Luo, H., Chen, Y., Gucek, M., Zhu, J., & Cao, H. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.02.004 · Cited by 279
A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility
Wei, M., Huang, F., Zhao, L., Zhang, Y., Yang, W., Wang, S., Li, M., Han, X., Ge, K., Qu, C., et al. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.102766 · Cited by 253
Self-citationThe oxysterol–CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils
Raccosta, L., Fontana, R., Maggioni, D., Lanterna, C., Villablanca, E. J., Paniccia, A., Musumeci, A., Chiricozzi, E., Trincavelli, M. L., Daniele, S., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130440 · Cited by 230
Immunological Quantitation and Localization of ACAT-1 and ACAT-2 in Human Liver and Small Intestine
Chang, C. C. Y., Sakashita, N., Ornvold, K., Lee, O., Chang, E. T., Dong, R., Lin, S., Lee, C.-Y. G., Strom, S. C., Kashyap, R., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003927200 · Cited by 228
Fibroblast growth factor 19 regulates skeletal muscle mass and ameliorates muscle wasting in mice
Benoit, B., Meugnier, E., Castelli, M., Chanon, S., Vieille-Marchiset, A., Durand, C., Bendridi, N., Pesenti, S., Monternier, P.-A., Durieux, A.-C., et al. (2017) · Nature Medicine · doi:10.1038/nm.4363 · Cited by 225
Rao, A., Kosters, A., Mells, J. E., Zhang, W., Setchell, K. D. R., Amanso, A. M., Wynn, G. M., Xu, T., Keller, B. T., Yin, H., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf4823 · Cited by 211
Wang, D. Q.-H., Tazuma, S., Cohen, D. E., & Carey, M. C. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00156.2003 · Cited by 210
Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications
Roma, M. G., Toledo, F. D., Boaglio, A. C., Basiglio, C. L., Crocenzi, F. A., & Sánchez Pozzi, E. J. (2011) · Clinical Science · doi:10.1042/cs20110184 · Cited by 208
Is bile acid a determinant of the gut microbiota on a high-fat diet?
Yokota, A., Fukiya, S., Islam, K. B. M. S., Ooka, T., Ogura, Y., Hayashi, T., Hagio, M., & Ishizuka, S. (2012) · Gut Microbes · doi:10.4161/gmic.21216 · Cited by 207
Uncoupling Nuclear Receptor LXR and Cholesterol Metabolism in Cancer
Bovenga, F., Sabbà, C., & Moschetta, A. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.03.002 · Cited by 207
Brufau, G., Stellaard, F., Prado, K., Bloks, V. W., Jonkers, E., Boverhof, R., Kuipers, F., & Murphy, E. J. (2010) · Hepatology · doi:10.1002/hep.23831 · Cited by 198
Miura, S., Mitsuhashi, N., Shimizu, H., Kimura, F., Yoshidome, H., Otsuka, M., Kato, A., Shida, T., Okamura, D., & Miyazaki, M. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-56 · Cited by 193
Lake, A. D., Novak, P., Shipkova, P., Aranibar, N., Robertson, D., Reily, M. D., Lu, Z., Lehman-McKeeman, L. D., & Cherrington, N. J. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.01.022 · Cited by 189
The acidic pathway of bile acid synthesis: Not just an alternative pathway
Pandak, W. M., & Kakiyama, G. (2019) · Liver Research · doi:10.1016/j.livres.2019.05.001 · Cited by 173
Mulder, T. P. J., van Platerink, C. J., Wijnand Schuyl, P. J., & van Amelsvoort, J. M. M. (2001) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(01)00285-7 · Cited by 172
Bile acid analysis in human disorders of bile acid biosynthesis
Vaz, F. M., & Ferdinandusse, S. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.03.003 · Cited by 165
Na, T., Shin, Y. K., Roh, K. J., Kang, S., Hong, I., Oh, S. J., Seong, J. K., Park, C. K., Choi, Y., & Lee, M. (2008) · Hepatology · doi:10.1002/hep.22740 · Cited by 161
Toxicity of oxysterols to human monocyte-macrophages
CLARE, K., Hardwick, S. J., Carpenter, K. L. H., Weeratunge, N., & Mitchinson, M. J. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05594-m · Cited by 145
Progress and challenges of selective Farnesoid X Receptor modulation
Massafra, V., Pellicciari, R., Gioiello, A., & van Mil, S. W. C. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.06.009 · Cited by 143
Setchell, K. D., Dumaswala, R., Colombo, C., & Ronchi, M. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37438-6 · Cited by 138
Li, C., Yang, W., Zhang, J., Zheng, X. M., Yao, Y., Tu, K., & Liu, Q. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15057124 · Cited by 138
Self-citationGeenes, V. L., Lövgren‐Sandblom, A., Benthin, L., Lawrance, D., Chambers, J., Gurung, V., Thornton, J., Chappell, L. C., Khan, E., Dixon, P. H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083828 · Cited by 130
Bile Acids Protect Expanding Hematopoietic Stem Cells from Unfolded Protein Stress in Fetal Liver
Sigurðsson, V., Takei, H., Soboleva, S., Radulović, V., Galeev, R., Siva, K., Leeb-Lundberg, L. M. F., Iida, T., Nittono, H., & Miharada, K. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.01.002 · Cited by 127
Loss of Cyp8b1 Improves Glucose Homeostasis by Increasing GLP-1
Kaur, A., Patankar, J. V., de Haan, W., Ruddle, P., Wijesekara, N., Groen, A. K., Verchere, C. B., Singaraja, R. R., & Hayden, M. R. (2015) · Diabetes · doi:10.2337/db14-0716 · Cited by 126
Inhibition of Fibroblast Growth Factor 19 Reduces Tumor Growth by Modulating β-Catenin Signaling
Pai, R., Dunlap, D., Qing, J., Mohtashemi, I., Hotzel, K., & French, D. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2325 · Cited by 119
Bertaggia, E., Jensen, K. K., Castro-Perez, J., Xu, Y., Di Paolo, G., Chan, R. B., Wang, L., & Haeusler, R. A. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00409.2016 · Cited by 118
Bile acid metabolism in early life: studies of amniotic fluid.
Nakagawa, M., & Setchell, K. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42749-x · Cited by 95
Ursodeoxycholic acid accelerates bile acid enterohepatic circulation
Zhang, Y., Jiang, R., Zheng, X., Lei, S., Huang, F., Xie, G., Kwee, S. A., Yu, H., Farrar, C. E., Sun, B., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14705 · Cited by 95
Self-citationBile salt hydrolases: Structure and function, substrate preference, and inhibitor development
Dong, Z., & Lee, B. H. (2018) · Protein Science · doi:10.1002/pro.3484 · Cited by 92
Oxysterols in Metabolic Syndrome: From Bystander Molecules to Bioactive Lipids
Guillemot‐Legris, O., Mutemberezi, V., & Muccioli, G. G. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.05.006 · Cited by 87
Ikegami, T., Hyogo, H., Honda, A., Miyazaki, T., Tokushige, K., Hashimoto, E., Inui, K., Matsuzaki, Y., & Tazuma, S. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0585-0 · Cited by 73
Matsuoka, K., Suzuki, M., Honda, C., Endo, K., & Moroi, Y. (2005) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2005.08.006 · Cited by 72
Bennett, M. J., McKnight, S. L., & Coleman, J. P. (2003) · Current Microbiology · doi:10.1007/s00284-003-4079-4 · Cited by 69
A specific cholesterol metabolic pathway is established in a subset of HCCs for tumor growth
Lu, M. H., Hu, X., Li, Q., Xiong, Y., Hu, G., Xu, J., Zhao, X., Wei, X.-X., Chang, C. C. Y., Liu, Y., et al. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt039 · Cited by 68
Su, K., Sabeva, N. S., Liu, J., Wang, Y., Bhatnagar, S., van der Westhuyzen, D. R., & Graf, G. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.360081 · Cited by 66
Liu, N., Feng, J., Lv, Y.-J., Liu, Q., Deng, J., Xia, Y., Guo, C.-Y., & Zhou, Y.-Q. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8011 · Cited by 65
Tissue and serum metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma
Han, J. S., Qin, W., Li, Z., Xu, A., Xing, H., Wu, H., Zhang, H., Wang, M.-D., Li, C., Liang, L., et al. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.10.039 · Cited by 63
Sulfated oxysterol, 25HC3S, is a potent regulator of lipid metabolism in human hepatocytes
Ren, S., Li, X., Rodríguez‐Agudo, D., Gil, G., Hylemon, P. B., & Pandak, W. M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.143 · Cited by 61
Suppression of ABCA1 by unsaturated fatty acids leads to lipid accumulation in HepG2 cells
Yang, Y., Jiang, Y., Wang, Y.-T., & An, W. (2010) · Biochimie · doi:10.1016/j.biochi.2010.04.002 · Cited by 60
Bai, Q., Zhang, X., Xu, L., Kakiyama, G., Heuman, D. M., Sanyal, A. J., Pandak, W. M., Yin, L., Xie, W., & Ren, S. (2012) · Metabolism · doi:10.1016/j.metabol.2011.11.014 · Cited by 58
Yu, H., Ni, Y., Bao, Y., Zhang, P., Zhao, A., Chen, T., Xie, G., Tu, Y., Zhang, L., Su, M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2884 · Cited by 58
Self-citationDiscovery of Bile Salt Hydrolase Inhibitors Using an Efficient High-Throughput Screening System
Smith, K., Zeng, X., & Lin, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085344 · Cited by 57
Nojima, K., Sugimoto, K., Ueda, H., Babaya, N., Ikegami, H., & Rakugi, H. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0258 · Cited by 53
Zhang, Y., Pan, Y., Lin, C., Zheng, Y., Sun, H., Zhang, H., Wang, J., Yuan, M., Duan, T., Du, Q., et al. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw025 · Cited by 50
Pannu, P. S., Allahverdian, S., & Francis, G. A. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.07.013 · Cited by 46
Kakiyama, G., Marques, D., Takei, H., Nittono, H., Erickson, S., Fuchs, M., Rodriguez-Agudo, D., Gil, G., Hylemon, P. B., Zhou, H., et al. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.01.011 · Cited by 45
Xu, L., Shen, S., Ma, Y., Kim, J. K., Rodriguez-Agudo, D., Heuman, D. M., Hylemon, P. B., Pandak, W. M., & Ren, S. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00337.2011 · Cited by 44
Seo, K., Bartley, G. E., Tam, C. C., Kim, H.-S., Kim, D., Chon, J., Kim, H., & YOKOYAMA, W. H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167680 · Cited by 44
Baranowski, M., Zabielski, P., Blachnio-Zabielska, A. U., Harasim, E., Chabowski, A., & Górski, J. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358675 · Cited by 42
Bile acid profiles in diabetic (db/db) mice and their wild type littermates
Chen, C., Hu, B., Wu, T., Zhang, Y., Xu, Y., Feng, Y., & Jiang, H. (2016) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2016.09.023 · Cited by 40
Pathak, P., & Chiang, J. Y. L. (2019) · Gene Expression · doi:10.3727/105221619x15529371970455 · Cited by 39
Metabolism of primary bile acids by Clostridium perfringens
Macdonald, I. A., Hutchison, D. M., Forrest, T. P., Bokkenheuser, V. D., Winter, J., & Holdeman, L. V. (1983) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(83)90336-9 · Cited by 34
Xu, L., Kim, J. K., Bai, Q., Zhang, X., Kakiyama, G., Min, H., Sanyal, A. J., Pandak, W. M., & Ren, S. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.081505 · Cited by 33
The gut–liver axis in hepatocarcinoma: a focus on the nuclear receptor FXR and the enterokine FGF19
Piglionica, M., Cariello, M., & Moschetta, A. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.08.005 · Cited by 31
Ma, H., Sales, V., Wolf, A. R., Subramanian, S., Matthews, T. J., Chen, M., Sharma, A., Gall, W., Kulik, W., Cohen, D. E., et al. (2017) · Endocrinology · doi:10.1210/en.2017-00288 · Cited by 29
Cholesterol metabolites and tumor microenvironment: the road towards clinical translation
Raccosta, L., Fontana, R., Corna, G., Maggioni, D., Moresco, M. A., & Russo, V. E. A. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1779-0 · Cited by 28
Oxysterol binding protein-related protein 8 mediates the cytotoxicity of 25-hydroxycholesterol
Li, J., Zheng, X., Lou, N., Zhong, W., & Yan, D. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m069906 · Cited by 27
Self-citationEdenharder, R., Pfützner, M., & Hammann, R. (1989) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(89)90061-1 · Cited by 22
Takeyama, Y., Uehara, Y., Anan, A., Morihara, D., Yokoyama, K., Takata, K., Tanaka, T., Irie, M., Iwata, K., Shakado, S., et al. (2017) · Medical Molecular Morphology · doi:10.1007/s00795-017-0166-7 · Cited by 14
EnaBILEing Growth in the Fetal Liver
Goessling, W., & North, T. E. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.03.019 · Cited by 1
Cited by
Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives
Liu, J., Tan, Y., Cheng, H., Zhang, D., Feng, W., & Peng, C. (2022) · Aging and disease · doi:10.14336/ad.2022.0104 · Cited by 529
“alternative pathway, the former of which plays major role [54].”
BackgroundKuang, J., Wang, J., Li, Y., Li, M., Zhao, M., Ge, K., Zheng, D., Cheung, K. C. P., Liao, B., Wang, S., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.07.011 · Cited by 321
Self-citationMetabolic Messengers: bile acids
Perino, A., & Schoonjans, K. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00559-z · Cited by 223
Interactive relationships between intestinal flora and bile acids
Guo, X., Okpara, E. S., Hu, W., Yan, C., Wang, Y., Liang, Q., Chiang, J. Y. L., & Han, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158343 · Cited by 206
“of hepatic stellate cells and the formation of hepatic fibrosis by activating the TGR5-ERK1/2 and P38 MAPK signaling pathways [50].”
BackgroundLi, M., Wang, S., Li, Y., Zhao, M., Kuang, J., Liang, D., Wang, J., Wei, M., Rajani, C., Ma, X., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29589-7 · Cited by 175
Self-citation
Metadata
- Authors
- Jia, W., Wei, M., Rajani, C., & Zheng, X.
- Venue
- Protein & Cell
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-11-30
- Volume
- 12
- Issue
- 5
- Pages
- 411-425
- ISSN
- 1674-800X (ISSN-L)
- 1674-8018
- OpenAlex
- W3109895489
- Cited by
- 325
- References
- 96
- FWCI
- 10.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.